Review



brca1 antibody  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc brca1 antibody
    Brca1 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brca1+antibody/pm41900138-175-0-31?v=Cell+Signaling+Technology+Inc
    Average 86 stars, based on 1 article reviews
    brca1 antibody - by Bioz Stars, 2026-07
    86/100 stars

    Images



    Similar Products

    95
    Proteintech primary antibodies
    Primary Antibodies, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brca1+antibody/pm41921649-56-21-25?v=Proteintech
    Average 95 stars, based on 1 article reviews
    primary antibodies - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc brca1 antibody
    Brca1 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brca1+antibody/pm41900138-175-0-31?v=Cell+Signaling+Technology+Inc
    Average 86 stars, based on 1 article reviews
    brca1 antibody - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    95
    Proteintech anti serbp1
    Anti Serbp1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brca1+antibody/pm41856985-77-8-14?v=Proteintech
    Average 95 stars, based on 1 article reviews
    anti serbp1 - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    95
    Proteintech anti brca1
    Anti Brca1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brca1+antibody/pm41856985-77-10-14?v=Proteintech
    Average 95 stars, based on 1 article reviews
    anti brca1 - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology anti brca1
    Anti Brca1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brca1+antibody/pmc13039405-318-27-28?v=Santa+Cruz+Biotechnology
    Average 96 stars, based on 1 article reviews
    anti brca1 - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology brca1
    A . MCF7 cells were treated for 1 h with DMSO or 50 μM PUGNAc ± 10 μM veliparib, irradiated with 6 Gy, fixed after 2 h and stained for 53BP1 and <t>BRCA1.</t> Representative images with 53BP1 foci (green), BRCA1 foci (red), and DAPI (blue) are shown. B , C . Plots of 53BP1 ( B ) and BRCA1 ( C ) foci per nucleus at 2 h after 6 Gy in DAPI Low and DAPI High cells. D . Cells were treated as in A but fixed after 24 h. E, F . Plots of 53BP1 ( E ) and BRCA1 ( F ) foci per nucleus at 24 h after 6 Gy in DAPI Low and DAPI High cells. For images, scale bar = 20 μm; inset is mean ± SEM foci per nucleus. For plots, red bars indicate mean ± SEM; ****, P < 0.0001; ***, P < 0.001; **, P < 0.01; *, P < 0.05; ns, P > 0.05 (unpaired t-test).
    Brca1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/brca1+antibody/pmc13036754-276-6-7?v=Santa+Cruz+Biotechnology
    Average 96 stars, based on 1 article reviews
    brca1 - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    Image Search Results


    A . MCF7 cells were treated for 1 h with DMSO or 50 μM PUGNAc ± 10 μM veliparib, irradiated with 6 Gy, fixed after 2 h and stained for 53BP1 and BRCA1. Representative images with 53BP1 foci (green), BRCA1 foci (red), and DAPI (blue) are shown. B , C . Plots of 53BP1 ( B ) and BRCA1 ( C ) foci per nucleus at 2 h after 6 Gy in DAPI Low and DAPI High cells. D . Cells were treated as in A but fixed after 24 h. E, F . Plots of 53BP1 ( E ) and BRCA1 ( F ) foci per nucleus at 24 h after 6 Gy in DAPI Low and DAPI High cells. For images, scale bar = 20 μm; inset is mean ± SEM foci per nucleus. For plots, red bars indicate mean ± SEM; ****, P < 0.0001; ***, P < 0.001; **, P < 0.01; *, P < 0.05; ns, P > 0.05 (unpaired t-test).

    Journal: Journal of cell science

    Article Title: Cancer metabolism in radiation sensitization: complementary roles of O-GlcNAc transferase (OGT) and PARP1

    doi: 10.1242/jcs.264322

    Figure Lengend Snippet: A . MCF7 cells were treated for 1 h with DMSO or 50 μM PUGNAc ± 10 μM veliparib, irradiated with 6 Gy, fixed after 2 h and stained for 53BP1 and BRCA1. Representative images with 53BP1 foci (green), BRCA1 foci (red), and DAPI (blue) are shown. B , C . Plots of 53BP1 ( B ) and BRCA1 ( C ) foci per nucleus at 2 h after 6 Gy in DAPI Low and DAPI High cells. D . Cells were treated as in A but fixed after 24 h. E, F . Plots of 53BP1 ( E ) and BRCA1 ( F ) foci per nucleus at 24 h after 6 Gy in DAPI Low and DAPI High cells. For images, scale bar = 20 μm; inset is mean ± SEM foci per nucleus. For plots, red bars indicate mean ± SEM; ****, P < 0.0001; ***, P < 0.001; **, P < 0.01; *, P < 0.05; ns, P > 0.05 (unpaired t-test).

    Article Snippet: The primary antibodies used were 53BP1, BRCA1 (Santa Cruz Biotechnology; sc-6954; 1:1,000), and RAD51 (Novus Biologicals; NB100–148; 1:1,000).

    Techniques: Irradiation, Staining

    A . MCF7 cells were incubated with 10 μM BrdU for 24 h, then treated for 1 h before 6 Gy with DMSO ± 10 μM veliparib or 50 μM PUGNAc + 10 μM veliparib, fixed after 24 h and single strand DNA detected with anti-BrdU antibody under non-denaturing conditions. Representative images show BrdU foci in red with DAPI in blue. B-D . Cells were treated for 1 h before 6 Gy with DMSO ± 10 μM veliparib or 50 μM PUGNAc + 10 μM veliparib, fixed after 24 h and probed for RPA ( B ), RAD51 ( C ) or BRCA1 ( D ). E-H . Plots of BrdU ( E ), RPA ( F ), RAD51 ( G ), and BRCA1 ( H ) foci per nucleus in at 24 h after 6 Gy. For images, scale bar = 20 μm; inset is mean ± SEM foci per nucleus. For plots, red bars indicate mean ± SEM; ****, P < 0.0001; ***, P < 0.001; **, P < 0.01; *, P < 0.05; ns, P > 0.05 (unpaired t-test).

    Journal: Journal of cell science

    Article Title: Cancer metabolism in radiation sensitization: complementary roles of O-GlcNAc transferase (OGT) and PARP1

    doi: 10.1242/jcs.264322

    Figure Lengend Snippet: A . MCF7 cells were incubated with 10 μM BrdU for 24 h, then treated for 1 h before 6 Gy with DMSO ± 10 μM veliparib or 50 μM PUGNAc + 10 μM veliparib, fixed after 24 h and single strand DNA detected with anti-BrdU antibody under non-denaturing conditions. Representative images show BrdU foci in red with DAPI in blue. B-D . Cells were treated for 1 h before 6 Gy with DMSO ± 10 μM veliparib or 50 μM PUGNAc + 10 μM veliparib, fixed after 24 h and probed for RPA ( B ), RAD51 ( C ) or BRCA1 ( D ). E-H . Plots of BrdU ( E ), RPA ( F ), RAD51 ( G ), and BRCA1 ( H ) foci per nucleus in at 24 h after 6 Gy. For images, scale bar = 20 μm; inset is mean ± SEM foci per nucleus. For plots, red bars indicate mean ± SEM; ****, P < 0.0001; ***, P < 0.001; **, P < 0.01; *, P < 0.05; ns, P > 0.05 (unpaired t-test).

    Article Snippet: The primary antibodies used were 53BP1, BRCA1 (Santa Cruz Biotechnology; sc-6954; 1:1,000), and RAD51 (Novus Biologicals; NB100–148; 1:1,000).

    Techniques: Incubation

    A, B . shScr, shOGT, and shOGA were induced for 48 h with 1 μg/ml doxycycline and cells were treated with 0 or 10 μM veliparib for 1 h prior to 6 Gy, fixed after 24 h and stained for BRCA1. Shown are representative images ( A ) and plots of BRCA1 foci per nucleus ( B ). C, D . Cells were treated as in A and stained for RPA. Shown are representative images ( C ) and plots of RPA foci per nucleus ( D ). E . shScr, shOGT, and shOGA cells were treated as in A and then lightly permeabilized, fixed and then stained with anti-DNA to detect cytosolic DNA (cytoDNA). Shown are representative pseudo-colored images, with cytoDNA in red, DAPI counterstain in blue, and overlays. For images, scale bar = 20 μm; inset is mean ± SEM foci per nucleus. For plots, red bars indicate mean ± SEM; ****, P < 0.0001; ***, P < 0.001; **, P < 0.01; *, P < 0.05; ns, P > 0.05 (unpaired t-test).

    Journal: Journal of cell science

    Article Title: Cancer metabolism in radiation sensitization: complementary roles of O-GlcNAc transferase (OGT) and PARP1

    doi: 10.1242/jcs.264322

    Figure Lengend Snippet: A, B . shScr, shOGT, and shOGA were induced for 48 h with 1 μg/ml doxycycline and cells were treated with 0 or 10 μM veliparib for 1 h prior to 6 Gy, fixed after 24 h and stained for BRCA1. Shown are representative images ( A ) and plots of BRCA1 foci per nucleus ( B ). C, D . Cells were treated as in A and stained for RPA. Shown are representative images ( C ) and plots of RPA foci per nucleus ( D ). E . shScr, shOGT, and shOGA cells were treated as in A and then lightly permeabilized, fixed and then stained with anti-DNA to detect cytosolic DNA (cytoDNA). Shown are representative pseudo-colored images, with cytoDNA in red, DAPI counterstain in blue, and overlays. For images, scale bar = 20 μm; inset is mean ± SEM foci per nucleus. For plots, red bars indicate mean ± SEM; ****, P < 0.0001; ***, P < 0.001; **, P < 0.01; *, P < 0.05; ns, P > 0.05 (unpaired t-test).

    Article Snippet: The primary antibodies used were 53BP1, BRCA1 (Santa Cruz Biotechnology; sc-6954; 1:1,000), and RAD51 (Novus Biologicals; NB100–148; 1:1,000).

    Techniques: Staining